MB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models | Biomedicines |  | 2023 | 59 | 183 | ||
| CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation | Journal of neuroinflammation | | 2022 | 238 | 123 | ||
| c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells | Cellular & Molecular Immunology | | 2021 | 339 | 229 | ||
| In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay | Bio-protocol | | 2018 | 326 | 567 | ||
| Activation of human B cells negatively regulates TGF-β1 production | Journal of Neuroinflammation | | 2017 | 592 | 322 | ||
| Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy | Frontiers in Immunology | | 2017 | 454 | 270 | ||
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports |  | 2017 | 600 | 4 | ||
| B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation | Scientific reports | | 2016 | 629 | 308 | ||
| Hepatocyte growth factor: A regulator of inflammation and autoimmunity | Autoimmunity reviews | | 2015 | 566 | 0 | ||
| The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells | Journal of neuroimmunology | | 2014 | 553 | 0 | ||
| TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3(+) Treg cells | European Journal of Immunology | | 2014 | 672 | 1 | ||
| Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells | The Journal of immunology | | 2014 | 698 | 3 | ||
| The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity | Journal of neuroinflammation | | 2013 | 632 | 393 | ||
| Nogo-A downregulation improves insulin secretion in mice | Diabetes | | 2013 | 709 | 338 | ||
| Selective APRIL blockade delays systemic lupus erythematosus in mouse | PloS one | | 2012 | 619 | 299 | ||
| IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis | Journal of neuroinflammation | | 2012 | 728 | 348 | ||
| Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients | PloS one | | 2012 | 694 | 274 | ||
| Antibody response in MOG35–55 induced EAE | Journal of neuroimmunology | | 2011 | 769 | 849 | ||
| Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action | CNS drugs | | 2011 | 608 | 0 | ||
| Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease | PloS one | | 2010 | 768 | 844 | ||
| Immunomodulatory effects of hepatocyte growth factor in experimental autoimmune encephalomyelitis | | 2010 | 1,088 | 1,470 | |||
| MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity | The Journal of experimental medicine | | 2010 | 703 | 1 | ||
| Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells | Proceedings of the National Academy of Sciences of the United States of America | | 2010 | 726 | 0 | ||
| Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis | Proceedings of the National Academy of Sciences of the United States of America | | 2009 | 647 | 0 | ||
| Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients | Journal of neuroimmunology | | 2008 | 677 | 0 | ||
| Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model | International immunology | | 2008 | 648 | 1 |
